PRKCQ
Protein kinase C theta type
Also known as: KPCT_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q04759
- Gene
- PRKCQ
- Ensembl
- ENSG00000065675
- Chromosome
- 10
- Canonical length
- 706 aa
- Protein class
- Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Centriolar satellite
OverviewNCBI Gene
Protein kinase C (PKC) is a family of serine- and threonine-specific protein kinases that can be activated by calcium and the second messenger diacylglycerol. PKC family members phosphorylate a wide variety of protein targets and are known to be involved in diverse cellular signaling pathways. PKC family members also serve as major receptors for phorbol esters, a class of tumor promoters. Each member of the PKC family has a specific expression profile and is believed to play a distinct role. The protein encoded by this gene is one of the PKC family members. It is a calcium-independent and phospholipid-dependent protein kinase. This kinase is important for T-cell activation. It is required for the activation of the transcription factors NF-kappaB and AP-1, and may link the T cell receptor (TCR) signaling complex to the activation of the transcription factors. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
706 residues, UniProt reviewed canonical sequence.
>Q04759|PRKCQ
1 MSPFLRIGLS NFDCGSCQSC QGEAVNPYCA VLVKEYVESE NGQMYIQKKP TMYPPWDSTF
61 DAHINKGRVM QIIVKGKNVD LISETTVELY SLAERCRKNN GKTEIWLELK PQGRMLMNAR
121 YFLEMSDTKD MNEFETEGFF ALHQRRGAIK QAKVHHVKCH EFTATFFPQP TFCSVCHEFV
181 WGLNKQGYQC RQCNAAIHKK CIDKVIAKCT GSAINSRETM FHKERFKIDM PHRFKVYNYK
241 SPTFCEHCGT LLWGLARQGL KCDACGMNVH HRCQTKVANL CGINQKLMAE ALAMIESTQQ
301 ARCLRDTEQI FREGPVEIGL PCSIKNEARP PCLPTPGKRE PQGISWESPL DEVDKMCHLP
361 EPELNKERPS LQIKLKIEDF ILHKMLGKGS FGKVFLAEFK KTNQFFAIKA LKKDVVLMDD
421 DVECTMVEKR VLSLAWEHPF LTHMFCTFQT KENLFFVMEY LNGGDLMYHI QSCHKFDLSR
481 ATFYAAEIIL GLQFLHSKGI VYRDLKLDNI LLDKDGHIKI ADFGMCKENM LGDAKTNTFC
541 GTPDYIAPEI LLGQKYNHSV DWWSFGVLLY EMLIGQSPFH GQDEEELFHS IRMDNPFYPR
601 WLEKEAKDLL VKLFVREPEK RLGVRGDIRQ HPLFREINWE ELERKEIDPP FRPKVKSPFD
661 CSNFDKEFLN EKPRLSFADR ALINSMDQNM FRNFSFMNPG MERLISLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PRKCQ can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 115 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 115 nTPM
- tongue: 105 nTPM
- thymus: 31 nTPM
- thyroid gland: 14 nTPM
- lymph node: 11 nTPM
- choroid plexus: 11 nTPM
Single-cell type
- myonuclei: 413 nCPM
- t-cells: 317 nCPM
- nk-cells: 275 nCPM
- retinal pigment epithelial cells: 217 nCPM
- choroid plexus epithelial cells: 212 nCPM
- megakaryocyte progenitors: 177 nCPM
Immune cell
- T-reg: 40 nTPM
- memory CD4 T-cell: 25 nTPM
- memory CD8 T-cell: 24 nTPM
- gdT-cell: 23 nTPM
- naive CD4 T-cell: 19 nTPM
- MAIT T-cell: 18 nTPM
Brain region
- choroid plexus: 23 nTPM
- white matter: 18 nTPM
- midbrain: 16 nTPM
- basal ganglia: 15 nTPM
- hypothalamus: 15 nTPM
- thalamus: 13 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.39
- gnomAD pLI
- 0.3
- gnomAD missense Z
- 2.36
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- axon guidance
- CD4-positive, alpha-beta T cell proliferation
- cell chemotaxis
- Fc-epsilon receptor signaling pathway
- inflammatory response
- intracellular signal transduction
- membrane protein ectodomain proteolysis
- negative regulation of insulin receptor signaling pathway
- negative regulation of T cell apoptotic process
- positive regulation of CD4-positive, alpha-beta T cell proliferation
- positive regulation of interleukin-17 production
- positive regulation of interleukin-2 production
- positive regulation of interleukin-4 production
- positive regulation of NF-kappaB transcription factor activity
- positive regulation of T cell activation
- positive regulation of T-helper 17 type immune response
- positive regulation of telomere maintenance
- regulation of cell growth
- regulation of DNA-templated transcription
- regulation of platelet aggregation
- positive regulation of T-helper 2 cell activation
Molecular functions
- ATP binding
- diacylglycerol-dependent serine/threonine kinase activity
- protein kinase activity
- protein serine kinase activity
- protein serine/threonine kinase activity
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- C2 domain
- Protein kinase domain
- AGC-kinase, C-terminal
- Protein kinase C-like, phorbol ester/diacylglycerol-binding domain
- Serine/threonine-protein kinase, active site
- Protein kinase-like domain superfamily
- Protein kinase C, delta/epsilon/eta/theta types
- Protein kinase, ATP binding site
- Protein kinase, C-terminal
- Diacylglycerol/phorbol-ester binding
- C2 domain superfamily
- C1-like domain superfamily
- Protein kinase domain
- Phorbol esters/diacylglycerol binding domain (C1 domain)
- Protein kinase C terminal domain
- Protein kinase C delta/epsilon/eta/theta, C2 domain
- Protein kinase C, theta
- Novel protein kinase C theta, catalytic domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PRKCQ in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PRKCQ as an antibody target. Whether an autoantibody or antibody against PRKCQ could matter depends on whether native PRKCQ is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PRKCQ is annotated at the cell surface, where native PRKCQ is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label PRKCQ as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...